CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash Flows from Operating Activities:
Net Loss	$ (885,297)	$ (815,546)
Adjustments To Reconcile Net Loss to Net Cash Used in Operating Activities -
Depreciation and Amortization	18,352	14,962
Gain on Sale of Assets	(26,948)	(17,901)
Stock-based Compensation Expense	194,133	42,750
Non-cash Consulting Expense	55,050	38,625
Non-cash Gain on Settlement of Liabilities by Issuing Common Stock	(22,050)	(39,222)
Changes in Operating Assets and Liabilities -
Accounts Receivable, net	(19,934)	(11,424)
Inventories	19,954	(259,864)
Prepaid Expenses	(35,012)	21,096
Accounts Payable	113,272	165,514
Customer Advances	(95,790)	74,400
Accrued Expenses	(65,943)	61,770
Net Cash Used in Operating Activities	(750,213)	(724,840)
Cash Flows from Investing Activities:
Additional Patent Costs	(4,230)	(10,972)
Purchases of Property and Equipment	(4,554)	(59,973)
Proceeds from Sale of Assets	26,948	17,901
Net Cash Provided by (Used in) Investing Activities	18,164	(53,044)
Cash Flows from Financing Activities:
Payment of Capital Lease Obligation	(2,094)	0
Gross Proceeds from Private Placement of Common Stock	700,000	980,291
Private Placement Expenses Incurred	(34,639)	(121,512)
Net Cash Provided by Financing Activities	663,267	858,779
Net Increase (Decrease) in Cash and Cash Equivalents	(68,782)	80,895
Cash and Cash Equivalents, Beginning of Period	241,051	202,380
Cash and Cash Equivalents, End of Period	172,269	283,275
Supplemental Disclosure of Cash Flow Information:
Cash Paid for Income Taxes	912	912
Supplemental disclosure of non-cash investing and financing activities
Issuance of Common Stock to Consultants	48,300	93,793
Acquisition of Manufacturing Equipment Under Capital Lease	$ 43,790	$ 0